drugset
drugset / Trial / NCT04698265

Efficacy of Intra-articular Injection of Human Amniotic Suspension Allograft and Platelet-rich Plasma in the Treatment of Knee Osteoarthritis.

NCT04698265 ↗

Unknown 150 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

A double-blind, randomized controlled trial designed to evaluate the symptomatic modulating efficacy of amniotic suspension allograft (ASA) in comparison to platelet-rich plasma (PRP), hyaluronic acid (HA) and normal saline (NS) in the injection treatment of knee osteoarthritis. The hypothesis is that ASA would provide the greatest functional improvement.

Timeline

Start
2021-01-01
Primary completion
2022-01-31
Completion
2023-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Human amniotic suspension allograft Cell therapy 20 mg Other
Subject Human amniotic suspension allograft Cell therapy 40 mg Other

Indications

osteoarthritis, knee